Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
The Urologic Clinics of North America
|
July 7, 2019
MicroRNAs as Biomarkers for Germ Cell Tumors
Lucia Nappi, Craig Nichols
Biomedicines
|
February 25, 2023
Primary Mediastinal Germ Cell Tumors: A Thorough Literature Review
Guliz Ozgun, Lucia Nappi
Future Oncology (London, England)
|
January 22, 2016
PARP inhibition in castration-resistant prostate cancer
Lucia Nappi, Martin E Gleave
Current Oncology Reports
|
February 10, 2022
Emerging Role of Biomarkers in Testicular Germ Cell Tumors
Maryam Soleimani, Christian Kollmannsberger, Lucia Nappi
Current Opinion in Urology
|
January 24, 2020
The role of micro-RNAs in management of germ cell tumors: future directions
Lucia Nappi, Christian Kollmannsberger, Craig Nichols
European Urology
|
December 28, 2020
Reply to John T. Lafin, Aditya Bagrodia's Letter to the Editor re: Lucia Nappi, Marisa Thi, Nabil Adra, et al. Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors. Eur Urol 2021;79:16-9
Lucia Nappi, Craig Nichols, Christian Kollmannsberger
Translational Andrology and Urology
|
November 22, 2021
Narrative review of developing new biomarkers for decision making in advanced testis cancer
Lucia Nappi, Craig Nichols, Christian Kollmannsberger
Future Oncology (London, England)
|
August 29, 2020
Avelumab and axitinib combination therapy for the treatment of advanced renal cell carcinoma
Maryam Soleimani, Lucia Nappi, Christian Kollmannsberger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2019
Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe
Christian K Kollmannsberger, Lucia Nappi, Craig Nichols
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2025
Novel High-dose Chemotherapy Regimens in Relapsed/Refractory Germ Cell Cancer: Have we made Progress?
Christian Kollmannsberger, Lucia Nappi, Craig R Nichols
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
The Urologic Clinics of North America
|
July 7, 2019
MicroRNAs as Biomarkers for Germ Cell Tumors
Lucia Nappi, Craig Nichols
Biomedicines
|
February 25, 2023
Primary Mediastinal Germ Cell Tumors: A Thorough Literature Review
Guliz Ozgun, Lucia Nappi
Future Oncology (London, England)
|
January 22, 2016
PARP inhibition in castration-resistant prostate cancer
Lucia Nappi, Martin E Gleave
Current Oncology Reports
|
February 10, 2022
Emerging Role of Biomarkers in Testicular Germ Cell Tumors
Maryam Soleimani, Christian Kollmannsberger, Lucia Nappi
Current Opinion in Urology
|
January 24, 2020
The role of micro-RNAs in management of germ cell tumors: future directions
Lucia Nappi, Christian Kollmannsberger, Craig Nichols
European Urology
|
December 28, 2020
Reply to John T. Lafin, Aditya Bagrodia's Letter to the Editor re: Lucia Nappi, Marisa Thi, Nabil Adra, et al. Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors. Eur Urol 2021;79:16-9
Lucia Nappi, Craig Nichols, Christian Kollmannsberger
Translational Andrology and Urology
|
November 22, 2021
Narrative review of developing new biomarkers for decision making in advanced testis cancer
Lucia Nappi, Craig Nichols, Christian Kollmannsberger
Future Oncology (London, England)
|
August 29, 2020
Avelumab and axitinib combination therapy for the treatment of advanced renal cell carcinoma
Maryam Soleimani, Lucia Nappi, Christian Kollmannsberger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2019
Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe
Christian K Kollmannsberger, Lucia Nappi, Craig Nichols
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2025
Novel High-dose Chemotherapy Regimens in Relapsed/Refractory Germ Cell Cancer: Have we made Progress?
Christian Kollmannsberger, Lucia Nappi, Craig R Nichols
Page
of 7